about
Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signaturesMutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma.Applied diagnostics in liver cancer. Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTORDopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychoticsAdvanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways
P50
description
researcher ORCID ID = 0000-0002-0511-5590
@en
wetenschapper
@nl
name
Nuria García-Díaz
@ast
Nuria García-Díaz
@en
Nuria García-Díaz
@es
Nuria García-Díaz
@nl
type
label
Nuria García-Díaz
@ast
Nuria García-Díaz
@en
Nuria García-Díaz
@es
Nuria García-Díaz
@nl
prefLabel
Nuria García-Díaz
@ast
Nuria García-Díaz
@en
Nuria García-Díaz
@es
Nuria García-Díaz
@nl
P106
P21
P31
P496
0000-0002-0511-5590